scholarly journals Antioxidants in Sport Sarcopenia

Nutrients ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2869
Author(s):  
Maria Michela Cesare ◽  
Francesca Felice ◽  
Veronica Santini ◽  
Rossella Di Stefano

The decline of skeletal muscle mass and strength that leads to sarcopenia is a pathology that might represent an emergency healthcare issue in future years. Decreased muscle mass is also a condition that mainly affects master athletes involved in endurance physical activities. Skeletal muscles respond to exercise by reshaping the biochemical, morphological, and physiological state of myofibrils. Adaptive responses involve the activation of intracellular signaling pathways and genetic reprogramming, causing alterations in contractile properties, metabolic status, and muscle mass. One of the mechanisms leading to sarcopenia is an increase in reactive oxygen and nitrogen species levels and a reduction in enzymatic antioxidant protection. The present review shows the recent experimental models of sarcopenia that explore molecular mechanisms. Furthermore, the clinical aspect of sport sarcopenia will be highlighted, and new strategies based on nutritional supplements, which may contribute to reducing indices of oxidative stress by reinforcing natural endogenous protection, will be suggested.

2019 ◽  
Vol 20 (16) ◽  
pp. 4002 ◽  
Author(s):  
Afonso Caricati-Neto ◽  
Paolo Ruggero Errante ◽  
Francisco Sandro Menezes-Rodrigues

Ischemic heart diseases (IHD) are the leading cause of death worldwide. Although the principal form of treatment of IHD is myocardial reperfusion, the recovery of coronary blood flow after ischemia can cause severe and fatal cardiac dysfunctions, mainly due to the abrupt entry of oxygen and ionic deregulation in cardiac cells. The ability of these cells to protect themselves against injury including ischemia and reperfusion (I/R), has been termed “cardioprotection”. This protective response can be stimulated by pharmacological agents (adenosine, catecholamines and others) and non-pharmacological procedures (conditioning, hypoxia and others). Several intracellular signaling pathways mediated by chemical messengers (enzymes, protein kinases, transcription factors and others) and cytoplasmic organelles (mitochondria, sarcoplasmic reticulum, nucleus and sarcolemma) are involved in cardioprotective responses. Therefore, advancement in understanding the cellular and molecular mechanisms involved in the cardioprotective response can lead to the development of new pharmacological and non-pharmacological strategies for cardioprotection, thus contributing to increasing the efficacy of IHD treatment. In this work, we analyze the recent advances in pharmacological and non-pharmacological strategies of cardioprotection.


2013 ◽  
Vol 218 (3) ◽  
pp. R13-R23 ◽  
Author(s):  
Milan Obradovic ◽  
Predrag Bjelogrlic ◽  
Manfredi Rizzo ◽  
Niki Katsiki ◽  
Mohamed Haidara ◽  
...  

Obesity is associated with aberrant sodium/potassium-ATPase (Na+/K+-ATPase) activity, apparently linked to hyperglycemic hyperinsulinemia, which may repress or inactivate the enzyme. The reduction of Na+/K+-ATPase activity in cardiac tissue induces myocyte death and cardiac dysfunction, leading to the development of myocardial dilation in animal models; this has also been documented in patients with heart failure (HF). During several pathological situations (cardiac insufficiency and HF) and in experimental models (obesity), the heart becomes more sensitive to the effect of cardiac glycosides, due to a decrease in Na+/K+-ATPase levels. The primary female sex steroid estradiol has long been recognized to be important in a wide variety of physiological processes. Numerous studies, including ours, have shown that estradiol is one of the major factors controlling the activity and expression of Na+/K+-ATPase in the cardiovascular (CV) system. However, the effects of estradiol on Na+/K+-ATPase in both normal and pathological conditions, such as obesity, remain unclear. Increasing our understanding of the molecular mechanisms by which estradiol mediates its effects on Na+/K+-ATPase function may help to develop new strategies for the treatment of CV diseases. Herein, we discuss the latest data from animal and clinical studies that have examined how pathophysiological conditions such as obesity and the action of estradiol regulate Na+/K+-ATPase activity.


Endocrinology ◽  
2014 ◽  
Vol 155 (1) ◽  
pp. 98-107 ◽  
Author(s):  
Bharath K. Mani ◽  
Jen-Chieh Chuang ◽  
Lilja Kjalarsdottir ◽  
Ichiro Sakata ◽  
Angela K. Walker ◽  
...  

Ghrelin is an orexigenic hormone secreted principally from a distinct population of gastric endocrine cells. Molecular mechanisms regulating ghrelin secretion are mostly unknown. Recently, norepinephrine (NE) was shown to enhance ghrelin release by binding to β1-adrenergic receptors on ghrelin cells. Here, we use an immortalized stomach-derived ghrelin cell line to further characterize the intracellular signaling pathways involved in NE-induced ghrelin secretion, with a focus on the roles of Ca2+ and cAMP. Several voltage-gated Ca2+ channel (VGCC) family members were found by quantitative PCR to be expressed by ghrelin cells. Nifedipine, a selective L-type VGCC blocker, suppressed both basal and NE-stimulated ghrelin secretion. NE induced elevation of cytosolic Ca2+ levels both in the presence and absence of extracellular Ca2+. Ca2+-sensing synaptotagmins Syt7 and Syt9 were also highly expressed in ghrelin cell lines, suggesting that they too help mediate ghrelin secretion. Raising cAMP with the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine also stimulated ghrelin secretion, although such a cAMP-mediated effect likely does not involve protein kinase A, given the absence of a modulatory response to a highly selective protein kinase A inhibitor. However, pharmacological inhibition of another target of cAMP, exchange protein-activated by cAMP (EPAC), did attenuate both basal and NE-induced ghrelin secretion, whereas an EPAC agonist enhanced basal ghrelin secretion. We conclude that constitutive ghrelin secretion is primarily regulated by Ca2+ influx through L-type VGCCs and that NE stimulates ghrelin secretion predominantly through release of intracellular Ca2+. Furthermore, cAMP and its downstream activation of EPAC are required for the normal ghrelin secretory response to NE.


2020 ◽  
Vol 66 (3) ◽  
pp. 196-207
Author(s):  
O.N. Poteryaeva ◽  
I.F. Usynin

The C-peptide is a fragment of proinsulin, the cleavage of which forms active insulin. In recent years, new information has appeared on the physiological effects of the C-peptide, indicating its positive effect on many organs and tissues, including the kidneys, nervous system, heart, vascular endothelium and blood microcirculation. Studies on experimental models of diabetes mellitus in animals, as well as clinical trials in patients with diabetes, have shown that the C-peptide has an important regulatory effect on the early stages of functional and structural disorders caused by this disease. The C-peptide exhibits its effects through binding to a specific receptor on the cell membrane and activation of downstream signaling pathways. Intracellular signaling involves G-proteins and Ca2+-dependent pathways, resulting in activation and increased expression of endothelial nitric oxide synthase, Na+/K+-ATPase and important transcription factors involved in apoptosis, anti-inflammatory and other intracellular defense mechanisms. This review gives an idea of the C-peptide as a bioactive endogenous peptide that has its own biological activity and therapeutic potential.


Author(s):  
Eleonora Vertecchi ◽  
Angela Iuzzolino ◽  
Erica Salvati

Telomeres are crucial structures that preserve genome stability. Their progressive erosion over rounds of DNA duplication determines senescence of cells and organisms. In a classic view, telomere biology impinges on intracellular signaling pathways regulating DNA damage repair and cell cycle arrest, but new roles of telomeric proteins and transcripts emerge from recent literature. Telomere biology diseases are human disorders associated to telomere attrition. This review wants to overview the recent findings in the field of telomere’s metabolism and to deepen molecular mechanisms of inherited and acquired telomeropathies, explaining new critical connections between telomeric factors and disease pathogenesis


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 3460-3460
Author(s):  
Markus Bosmann ◽  
Julian Roewe ◽  
Dennis Riehl ◽  
Matthias Theobald ◽  
Peter A. Ward

Abstract The central nervous system has the ability for modulating immune responses, but the molecular mechanisms of such interactions are only partly understood. Interleukin-27 (IL-27) is a heterodimeric protein and structurally related to the IL-12 family of cytokines. IL-27 is composed of the subunits EBI3 and p28. The biological functions of IL-27 have been described as either anti-inflammatory or pro-inflammatory depending on the experimental models studied. In the current study, we investigated how production of Interleukin-27 (IL-27) is regulated by neuroendocrine hormones. We focused our work on the subunit p28, since EBI3 is also present in IL-35 and therefore is not a specific component of IL-27. First, we used F4/80+CD11b+ macrophages from C57BL/6J mice derived either from the bone marrow (BMDM) or elicited by intra-peritoneal injection of thioglycollate (PEM). IL-27 was abundantly expressed and secreted in cultures of macrophages (PEM and BMDM) when these cells were activated by lipopolysaccharide (LPS). The addition of neuroendocrine hormones of the sympathetic nervous system (adrenaline and noradrenaline) greatly reduced the capacity of LPS-activated macrophages to generate IL-27p28 at all time points studied (0-24 h; Fig. 1A, 1B). The effects of these catecholamines were dose-dependent over a range of 1 µM – 0.01 µM. To study the intracellular signaling events related to suppression of IL-27p28 by neuroendocrine hormones, we used bead-based multiplexing assays with antibodies specific for phosphorylated signaling proteins (Akt, c-Jun, CREB, ERK1/2, JNK, MEK1, NFκB, p38 MAPK, STAT3). Activation of macrophages with LPS within 20-60 min induced a 3-5-fold increase in phosphorylation of multiple signaling pathways including c-Jun N-terminal kinases (JNK) at threonine-183/tyrosine-185. Treatment of macrophages with adrenaline or noradrenaline greatly reduced phosphorylation of JNK following LPS. Inhibition of JNK-signaling using the small molecule inhibitor, SP600125, reduced the release of IL-27p28 from macrophages. This suggested that neuroendocrine hormones (adrenaline, noradrenaline) modulate IL-27p28-dependent immune responses via a JNK-dependent mechanism. To investigate the relevance of our findings regarding neuroendocrine regulation of IL-27p28 during acute inflammation, we used a model of endotoxic shock induced by intra-peritoneal injection of LPS (10 mg/kg body weight). Mice with genetic deficiency of the IL-27 receptor (IL-27RA-/-, WSX-1-/-) were significantly protected following endotoxic shock as compared to wild type control mice. These data suggest that IL-27 signaling promotes lethal outcomes of endotoxic shock. To further characterize the role of catecholamines, C57BL/6J mice underwent surgical removal of the adrenal glands for interrupting the secretion of adrenaline, noradrenaline and glucocorticoids. When adrenalectomized mice were subjected to endotoxic shock, these animals displayed 2-3-fold higher concentrations of IL-27p28 in plasma after 8 h. This observation may not only be explained by reduced concentrations of catecholamines in adrenalectomized mice, but also by a disruption of the pituitary-adrenal axis, since glucocorticoids in vitro also suppressed IL-27p28. In summary, these data describe novel interactions of endocrine transmitters of the nervous system and macrophage-derived IL-27. The hyperproduction of IL-27 observed in adrenalectomized mice provides a new explanation for the known susceptibility of such animals in experimental models of sepsis and other acute inflammatory diseases. Disclosures: No relevant conflicts of interest to declare.


Author(s):  
И.А. Степанов ◽  
В.А. Белобородов ◽  
М.А. Шамеева

В обзоре освещены данные современной литературы, посвященные изучению молекулярно-генетических механизмов гетеротопической оссификации (ГО). ГО представляет собой процесс образования пластинчатой кости в мягких тканях, не имеющих остеогенных свойств. В патогенезе формирования очагов ГО важнейшую роль играет ряд внутриклеточных сигнальных путей, ответственных за направление дифференцировки мезенхимальных стволовых клеток по пути остеогенеза. Представлен анализ экспериментальных исследований, изучающих молекулярные механизмы ГО. Авторами изложены современные данные о молекулярных терапевтических подходах к лечению и профилактике ГО. Обозначены актуальные, остающиеся нерешенными вопросы, что диктует необходимость проведения дальнейших экспериментальных и клинических исследований проблемы гетеротопической оссификации. This review addressed molecular and genetic mechanisms of heterotopic ossification (HO). HO is a process of lamellar bone formation in soft tissues lacking osteogenic properties. Several intracellular signaling pathways for differentiation of mesenchymal stem cells along with the osteogenesis pathway play an important role in the pathogenesis of HO formation. This review analyzed experimental studies of HO molecular mechanisms. The authors presented state-of-the-art information about molecular therapeutic approaches in HO treatment and prevention and identified relevant but still unresolved issues, which warrant further experimental and clinical studies.


2020 ◽  
Author(s):  
Yan Wang ◽  
Mengqi Zhang ◽  
Zhikun Huan ◽  
Shanshan Shao ◽  
Xiujuan Zhang ◽  
...  

Previous studies suggest that postmenopausal osteoarthritis is linked to a decrease in estrogen levels. However, whether follicle-stimulating hormone (FSH), the upstream hormone of estrogen, affects cartilage destruction and thus contributes to the onset of osteoarthritis has never been explored. To evaluate the potential involvement of FSH in joint degeneration and to identify the molecular mechanisms through which FSH influences chondrocytes, mouse cartilage chondrocytes and the ATDC5 chondrocyte cell line were treated with FSH and inhibitors of intracellular signaling pathways. We observed that FSH induces chondrocyte dedifferentiation by decreasing type II collagen (Coll-II) synthesis. Chondrocyte cytoskeleton reorganization was also observed after FSH treatment. The FSH-induced decrease in Coll-II was rescued by ERK-1/2 inhibition but aggravated by p38 inhibition. In addition, knocking down the FSH receptor (Fshr) by using Fshr siRNA abolished chondrocyte dedifferentiation, as indicated by the increased expression of Coll-II. Inhibition of the protein Gαi by pertussis toxin (PTX) also restored FSH-inhibited Coll-II, suggesting that Gαi is downstream of FSHR in chondrocyte dedifferentiation. FSHβ antibody blockade prevented cartilage destruction and cell loss in mice. Moreover, decreased Coll-II staining due to the progression of aging could be rescued by blocking FSH. Thus, we suggest that high circulating FSH, independent of estrogen, is an important regulator in chondrocyte dedifferentiation and cartilage destruction.


Sign in / Sign up

Export Citation Format

Share Document